evidence: However, only the TCF group showed statistically and clinically meaningful improvement in global QOL (P = 0.001).
intervention: docetaxel, cisplatin, 5 FU (TCF)
comparator: epirubicin, cisplatin, 5-FU (ECF)
outcome: global QOL , social and emotional functioning, pain  and sleep difficulties